Chronic Kidney Disease

Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m
High‑Stakes CKM Heart Failure Decisions

Robert Mentz

Watch time: 7m 27s

Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al

Read time: 26m 40s
ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Metabolic Factors Now Key Drivers of Heart Failure

Radcliffe Cardiology

Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

Chim C Lang, Bianca Rocca, Samira Bell, et al

Watch time: 14m 14s
RELAXIN-LA Trial: Volenrelaxin Linked to Worsening Congestion in HFpEF

Radcliffe Cardiology

Radcliffe CKM

James Burton, Clara Bonanad Lozano, Csaba Kovesdy, et al

Watch time: 1h 1m 16s (5 videos)

Wy Jin Quah, Maizatu Akma Sulong, Ghazali Ahmad, et al

Read time: 21m 40s

Andrew JS Coats, Stefan Anker

Fausto J Pinto, John Spertus, , et al

Watch time: 2s (19 videos)

Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al

Read time: 26m 40s
Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Dinesh Khullar, Anish Kumar Gupta, Kulwant Singh

Read time: 21m 40s

James Burton, Clara Bonanad Lozano, Csaba Kovesdy, et al

Watch time: 1h 1m 16s (5 videos)

David K Ryan, Debasish Banerjee, Fadi Jouhra

Read time: 10m

Vijay Chopra, Deepak L Bhatt, George L Bakris, et al

Navdeep Tangri, James Burton, David Wheeler

ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s

Laibah Arshad Khan, Adeena Jamil, Stephen J Greene, et al

Read time: 37m 48s

Zaki Akhtar, Lisa WM Leung, Christos Kontogiannis, et al

Read time: 26m 9s

Media

Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 18m (7 videos)

Fausto J Pinto, John Spertus, , et al

Watch time: 2s (19 videos)
Heart Failure in Focus Podcast - Ep 6: Cardiorenal Care in Practice

Muthiah Vaduganathan, ,

Listen time: 20m 40s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello , et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello , et al

Paul Kalra

Watch time: 12m 41s (2 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Andrew JS Coats, Stefan Anker

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Shelley Zieroth, ,

Watch time: 20m 16s (3 videos)

Media

Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m
High‑Stakes CKM Heart Failure Decisions

Robert Mentz

Watch time: 7m 27s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

Chim C Lang, Bianca Rocca, Samira Bell, et al

Watch time: 14m 14s

James Burton, Clara Bonanad Lozano, Csaba Kovesdy, et al

Watch time: 1h 1m 16s (5 videos)

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong , et al

Watch time: 1h 3m 30s

Clara Saldarriaga

Watch time: 4m 37s (11 videos)
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
Plenary Session 6 – Anaemia and iron deficiency

John GF Cleland, Gerasimos Filippatos, Ewa Jankowska, et al

Watch time: 54m 56s
Guideline directed therapy for CRM disease: the evidence base

Lars H Lund, Marco Metra, Nikolaus Marx, et al

Watch time: 1h 2m 27s

Articles

Arrhythmias in Chronic Kidney Disease

Zaki Akhtar

,

Lisa WM Leung

,

Christos Kontogiannis

,

Isaac Chung

,

Khalid Bin Waleed

,

Mark M Gallagher

,

Published:

07 March 2022

Citation:

European Cardiology Review 2022;17:e05.

DOI:

https://doi.org/10.15420/ecr.2021.52
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 243
  • Citations: 28
  • Read time: 26m 9s

CVD in CKD Patients: Heart–Kidney Team-Based Approach

Gautam R Shroff

,

Michelle D Carlson

,

Roy O Mathew

,

Published:

07 December 2021

Citation:

European Cardiology Review 2021;16:e48.

DOI:

https://doi.org/10.15420/ecr.2021.30
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 114
  • Citations: 13